BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND MUC16, CA125, CA-125 AND Diagnosis
1731 results:

  • 1. Serum anti-CFL1, anti-EZR, and anti-CYPA autoantibody as diagnostic markers in ovarian cancer.
    Cheng Y; Li Q; Sun G; Li T; Zou Y; Ye H; Wang K; Shi J; Wang P
    Sci Rep; 2024 Apr; 14(1):9757. PubMed ID: 38684875
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Primary lymphoma of the female genital tract masquerading as gynecological malignancy.
    Shi S; Li W; Ni G; Ding J; Liu Y; Wu H; Zhang Z; Ding Z
    BMC Womens Health; 2024 Apr; 24(1):247. PubMed ID: 38637800
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Efficient CAR T cell targeting of the ca125 extracellular repeat domain of muc16.
    Casey NP; Kleinmanns K; Forcados C; Gelebart PF; Joaquina S; Lode M; Benard E; Kaveh F; Caulier B; Helgestad Gjerde C; García de Jalón E; Warren DJ; Lindemann K; Rokkones E; Davidson B; Myhre MR; Kvalheim G; Bjørge L; McCormack E; Inderberg EM; Wälchli S
    J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38604812
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Bayesian and deep-learning models applied to the early detection of ovarian cancer using multiple longitudinal biomarkers.
    Abrego L; Zaikin A; Marino IP; Krivonosov MI; Jacobs I; Menon U; Gentry-Maharaj A; Blyuss O
    Cancer Med; 2024 Apr; 13(7):e7163. PubMed ID: 38597129
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Sialyl-Tn serves as a potential therapeutic target for ovarian cancer.
    Al-Alem L; Prendergast JM; Clark J; Zarrella B; Zarrella DT; Hill SJ; Growdon WB; Pooladanda V; Spriggs DR; Cramer D; Elias KM; Nazer RI; Skates SJ; Behrens J; Dransfield DT; Rueda BR
    J Ovarian Res; 2024 Apr; 17(1):71. PubMed ID: 38566237
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Evaluation of the Cutoff Point and Diagnostic Value of the Neutrophil-to-Lymphocyte Ratio in Predicting ovarian cancer Compared to Pathological Findings.
    Hosseini MS; Amiri F; Rezapour M; Ashraf Ganjoie T; Farzaneh F; Arab M; Talayeh M; Beheshti Rooy R; Hadi F
    Asian Pac J Cancer Prev; 2024 Mar; 25(3):971-976. PubMed ID: 38546079
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Clinical analysis of 12 cases of ovarian yolk sac tumor].
    Liu J; Chu HJ; Shan YP; Song WJ; Chen AP
    Zhonghua Fu Chan Ke Za Zhi; 2024 Mar; 59(3):210-214. PubMed ID: 38544450
    [No Abstract]    [Full Text] [Related]  

  • 8. Interrogating the Theranostic Capacity of a muc16-Targeted Antibody for ovarian cancer.
    Mack KN; Samuels ZV; Carter LM; Viray TD; Mandleywala K; Brooks CL; Hollingsworth MA; Radhakrishnan P; Lewis JS
    J Nucl Med; 2024 Apr; 65(4):580-585. PubMed ID: 38485271
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Successful Treatment of a Case of Crescentic Glomerulonephritis in a Patient with Primary Peritoneal Carcinoma: A case report.
    Zribi A; Nagy A; Riyami MA; Burney IA
    Sultan Qaboos Univ Med J; 2024 Feb; 24(1):119-122. PubMed ID: 38434475
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Diagnostic value of plasma-derived exosomal miR-223 for epithelial ovarian cancer.
    Yang L; Yang Z; Liu Z; Qi N; Tao L
    BMC Womens Health; 2024 Mar; 24(1):150. PubMed ID: 38431592
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. An integrated machine learning-based model for joint diagnosis of ovarian cancer with multiple test indicators.
    Feng Y
    J Ovarian Res; 2024 Feb; 17(1):45. PubMed ID: 38378582
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Noninvasive serum N-glycans associated with ovarian cancer diagnosis and precancerous lesion prediction.
    Liu S; Tu C; Zhang H; Huang H; Liu Y; Wang Y; Cheng L; Liu BF; Ning K; Liu X
    J Ovarian Res; 2024 Jan; 17(1):26. PubMed ID: 38281033
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Comparison of the ADNEX and ROMA risk prediction models for the diagnosis of ovarian cancer: a multicentre external validation in patients who underwent surgery.
    Landolfo C; Ceusters J; Valentin L; Froyman W; Van Gorp T; Heremans R; Baert T; Wouters R; Vankerckhoven A; Van Rompuy AS; Billen J; Moro F; Mascilini F; Neumann A; Van Holsbeke C; Chiappa V; Bourne T; Fischerova D; Testa A; Coosemans A; Timmerman D; Van Calster B
    Br J Cancer; 2024 Apr; 130(6):934-940. PubMed ID: 38243011
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. ovarian clear cell carcinoma with uterine intramural recurrence: Case report of ovarian clear cell carcinoma with fertility sparing treatment.
    Chang TY; Yeh CY; Yang CY; Lin WC; Huang CC; Hung YC
    Taiwan J Obstet Gynecol; 2024 Jan; 63(1):90-94. PubMed ID: 38216278
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Artificial intelligence-based models enabling accurate diagnosis of ovarian cancer using laboratory tests in China: a multicentre, retrospective cohort study.
    Cai G; Huang F; Gao Y; Li X; Chi J; Xie J; Zhou L; Feng Y; Huang H; Deng T; Zhou Y; Zhang C; Luo X; Xie X; Gao Q; Zhen X; Liu J
    Lancet Digit Health; 2024 Mar; 6(3):e176-e186. PubMed ID: 38212232
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Autoantibodies, antigen-autoantibody complexes and antigens complement ca125 for early detection of ovarian cancer.
    Young Han C; Bedia JS; Yang WL; Hawley SJ; Bergan L; Hopper M; Celestino J; Guo J; Gornet TG; Soosaipillai A; Yang H; Doskocil SD; Lokshin AE; Handy BC; Diamandis EP; Moore RG; Lu KH; Lu Z; Anderson KS; Drescher CW; Skates SJ; Bast RC
    Br J Cancer; 2024 Mar; 130(5):861-868. PubMed ID: 38195887
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Exosomal biomarkers in the differential diagnosis of ovarian tumors: the emerging roles of ca125, HE4, and C5a.
    Shi H; Liu L; Deng X; Xing X; Zhang Y; Djouda Rebecca Y; Han L
    J Ovarian Res; 2024 Jan; 17(1):4. PubMed ID: 38178252
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Early ovarian cancer Detection in the Age of Fallopian Tube Precursors: A Systematic Review.
    Greenwood A; Woodruff ER; Nguyen C; Piper C; Clauset A; Brubaker LW; Behbakht K; Bitler BG
    Obstet Gynecol; 2024 Mar; 143(3):e63-e77. PubMed ID: 38176019
    [TBL] [Abstract] [Full Text] [Related]  

  • 19.
    Hu X; Li W; Li X; Li D; Cai J; Wang P
    Sci Rep; 2024 Jan; 14(1):347. PubMed ID: 38172241
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Magnetic resonance imaging for the diagnosis of malignant mixed Mullerian tumor of ovary: Two case reports.
    Jin X; Zhu P; Fan S; Dai J
    Medicine (Baltimore); 2023 Dec; 102(50):e36569. PubMed ID: 38115369
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 87.